Clinical Trials
Phase 3 Trial of Rova T as Second-line Therapy for Advanced Small-Cell Lung Cancer Halted
AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine...
News
Pharma torch bearers congregate to select industryโs best in class in Mumbai
The India Pharma Awards, conducted by UBM India, Indiaโs leading B2B exhibitions organizer, concluded the second and final round of jury selection at The...
Press Releases
Recipharmโs proprietary molecule Erdosteine recognised as COPD treatment
Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee...
Press Releases
Clinerion welcomes the Santa Casa da Misericordia hospital to the Patient Network Explorer hospital network
The Santa Casa da Misericordia hospital of Porto Alegre, Brazil, will expand Clinerionโs network of partner hospitals in Brazil. Patients from the hospitalโs seven...
Press Releases
The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors
The EORTC Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagenโs Cancer Immunotherapy Array to identify autoantibody biomarkers that investigate...
Press Releases
The 3rd edition of the India Pharma Week gears up for a grand debut in Delhi-NCR
UBM India, India's leading B2B exhibition organizer, is all set to bring in the third edition of the widely appreciated India Pharma Week, a...
Press Releases
The new tube holder from Greiner Bio-One impresses thanks to its versatility
The new VACUETTEยฎ branded SAFELINK tube holder facilitates quick and easy blood collection. The tube can be used in combination with all medical products...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















